AI assistant
Sending…
IN8BIO, INC. — Director's Dealing 2024
Feb 8, 2024
35200_dirs_2024-02-08_cfe3e754-701f-4146-b71e-71fa12067640.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IN8BIO, INC. (INAB)
CIK: 0001740279
Period of Report: 2024-02-07
Reporting Person: Epperly Corinne (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-02-07 | Stock Option (right to buy) | $1.22 | A | 12500 | Acquired | 2034-02-07 | Common Stock (12500) | Direct |
Footnotes
F1: One thirty-sixth (1/36th) of the shares subject to the option shall vest in equal monthly installments commencing on March 7, 2024, subject to the Reporting Person continuing to provide service through each such date.
More from IN8BIO, INC.
Capital/Financing Update
2026
Jun 1
Capital/Financing Update
2026
Jun 1
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 7
Share Issue/Capital Change
2026
May 7
Share Issue/Capital Change
2026
May 7
Regulatory Filings
2026
May 7
Share Issue/Capital Change
2026
May 7
Regulatory Filings
2026
May 7